{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:38:01Z","timestamp":1772239081812,"version":"3.50.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.2215\/cjn.06510909","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T22:24:05Z","timestamp":1267741445000},"page":"905-911","source":"Crossref","is-referenced-by-count":180,"title":["Cholecalciferol Supplementation in Hemodialysis Patients"],"prefix":"10.2215","volume":"5","author":[{"given":"Patr\u00edcia Jo\u00e3o","family":"Matias","sequence":"first","affiliation":[]},{"given":"Cristina","family":"Jorge","sequence":"additional","affiliation":[]},{"given":"Carina","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Mar\u00edlia","family":"Borges","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Aires","sequence":"additional","affiliation":[]},{"given":"Tiago","family":"Amaral","sequence":"additional","affiliation":[]},{"given":"C\u00e9lia","family":"Gil","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Cortez","sequence":"additional","affiliation":[]},{"given":"An\u00edbal","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-25-20230601","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease: A single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"key":"R2-25-20230601","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R3-25-20230601","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1523-1755.1999.0550031019.x","article-title":"Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialysed patients with chronic renal failure","volume":"55","author":"Ishimura","year":"1999","journal-title":"Kidney Int"},{"key":"R4-25-20230601","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.me.43.020192.001303","article-title":"The use of 1,25-dihydroxyvitamin D3 in early renal failure","volume":"43","author":"Goodman","year":"1992","journal-title":"Annu Rev Med"},{"key":"R5-25-20230601","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ndt\/15.4.460","article-title":"What's new in vitamin D for the nephrologist?","volume":"15","author":"Schroeder","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R6-25-20230601","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"R8-25-20230601","first-page":"3713","article-title":"The dependency of vitamin D status on body mass index, gender, age and season","volume":"29","author":"Lagunova","year":"2009","journal-title":"Anticancer Res"},{"key":"R9-25-20230601","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/79.3.362","article-title":"Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis","volume":"79","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R10-25-20230601","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int"},{"key":"R11-25-20230601","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1525-139X.2007.00302.x","article-title":"Expanding role for vitamin D in chronic kidney disease: Importance of blood 25-OH-D levels and extra-renal 1\u03b1-hydroxylase in the classical and non-classical actions of 1\u03b1,25-dihydroxyvitamin D3","volume":"20","author":"Jones","year":"2007","journal-title":"Semin Dial"},{"key":"R12-25-20230601","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/01.HYP.30.5.1289","article-title":"Association of calcitriol and blood pressure in normotensive men","volume":"30","author":"Kristal-Boneh","year":"1997","journal-title":"Hypertension"},{"key":"R13-25-20230601","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","article-title":"Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure","volume":"41","author":"Zittermann","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R14-25-20230601","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2006060573","article-title":"Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency","volume":"18","author":"London","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R15-25-20230601","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/gfn502","article-title":"25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients","volume":"24","author":"Matias","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R17-25-20230601","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(97)12331-5","article-title":"Electrolyte quintet: Calcium","volume":"352","author":"Bushinsky","year":"1998","journal-title":"Lancet"},{"key":"R18-25-20230601","first-page":"249","article-title":"Brain natriuretic peptide levels predict morbidity and mortality in haemodialysis patients","volume":"23","author":"Matias","year":"2009","journal-title":"Port J Nephrol Hypertens"},{"key":"R19-25-20230601","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"R20-25-20230601","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jn\/135.2.317","article-title":"Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D","volume":"135","author":"Hollis","year":"2005","journal-title":"J Nutr"},{"key":"R21-25-20230601","first-page":"686","article-title":"Renal bioactivation of vitamin D and its key modulators","volume":"17","author":"Sato","year":"2007","journal-title":"Clin Calcium"},{"key":"R22-25-20230601","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1172\/JCI110501","article-title":"Evidence for extrarenal production of 1 alpha, 25-dihydroxyvitamin D in man","volume":"69","author":"Lambert","year":"1982","journal-title":"J Clin Invest"},{"key":"R23-25-20230601","doi-asserted-by":"crossref","first-page":"c58","DOI":"10.1159\/000151534","article-title":"Evidence for persistent vitamin d 1-alpha-hydroxylation in hemodialysis patients: Evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment","volume":"110","author":"Jean","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"R24-25-20230601","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jcem-72-1-157","article-title":"Extrarenal production of calcitriol in normal and uremic humans","volume":"72","author":"Dusso","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-25-20230601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1677\/jme.0.0250141","article-title":"1 Alpha-hydroxylase and the action of vitamin D","volume":"25","author":"Hewison","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"R26-25-20230601","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"R27-25-20230601","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2005.02226.x","article-title":"Vitamin D and the elderly","volume":"62","author":"Mosekilde","year":"2005","journal-title":"Clin Endocrinol (Oxf"},{"key":"R28-25-20230601","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2006.02.016","article-title":"Vitamin D physiology","volume":"92","author":"Lips","year":"2006","journal-title":"Prog Biophys Mol Biol"},{"key":"R29-25-20230601","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0039-128X(87)90078-X","article-title":"Side-chain hydroxylation of vitamin D3 and its physiological implications","volume":"49","author":"Jones","year":"1987","journal-title":"Steroids"},{"key":"R30-25-20230601","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj2620173","article-title":"Target cell metabolism of 1,25-(OH)2D3 to calcitroic acid: Evidence for a pathway in kidney and bone involving 24-oxidation","volume":"262","author":"Makin","year":"1989","journal-title":"Biochem J"},{"key":"R31-25-20230601","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.ki.5000394","article-title":"25-Hydroxyvitamin D3 suppresses PTH synthesis and secretion by bovine parathyroid cells","volume":"70","author":"Ritter","year":"2006","journal-title":"Kidney Int"},{"key":"R32-25-20230601","doi-asserted-by":"crossref","first-page":"c121","DOI":"10.1159\/000074837","article-title":"Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure: A synergistic effect with r-HuEpo","volume":"95","author":"Aucella","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"R33-25-20230601","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5414\/CNP66275","article-title":"Immunomodulation by 1,25-dihydroxyvitamin D3: Therapeutic implications in hemodialysis and renal transplantation","volume":"66","author":"Mathieu","year":"2006","journal-title":"Clin Nephrol"},{"key":"R34-25-20230601","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1542-4758.2005.01167.x","article-title":"Immunomodulating effects of vitamin D analogs in hemodialysis patients","volume":"9","author":"Seibert","year":"2005","journal-title":"Hemodial Int"},{"key":"R35-25-20230601","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2006.02633.x","article-title":"Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients","volume":"65","author":"Targher","year":"2006","journal-title":"Clin Endocrinol (Oxf"},{"key":"R36-25-20230601","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1093\/ndt\/gfn339","article-title":"Daily oral 25-hydroxycholecalciferol supplementation for vitamin d deficiency in haemodialysis patients: Effects on mineral metabolism and bone markers","volume":"23","author":"Jean","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R37-25-20230601","doi-asserted-by":"crossref","first-page":"c132","DOI":"10.1159\/000098645","article-title":"Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients","volume":"105","author":"Saab","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"R38-25-20230601","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R39-25-20230601","doi-asserted-by":"crossref","first-page":"c162","DOI":"10.1159\/000092914","article-title":"Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients","volume":"103","author":"Racek","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"R40-25-20230601","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1445-5994.2006.01136.x","article-title":"Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients","volume":"36","author":"Zeng","year":"2006","journal-title":"Intern Med J"},{"key":"R41-25-20230601","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N Engl J Med"},{"key":"R42-25-20230601","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000013385","article-title":"Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis","volume":"18","author":"Nitta","year":"1998","journal-title":"Am J Nephrol"},{"key":"R43-25-20230601","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jsbmb.2004.03.004","article-title":"Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure","volume":"89","author":"Li","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R44-25-20230601","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0895-7061(95)00154-H","article-title":"Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-age men","volume":"8","author":"Lind","year":"1995","journal-title":"Am J Hypertens"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01277230-201005000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T17:08:09Z","timestamp":1685639289000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01277230-201005000-00025"}},"subtitle":["Effects on Mineral Metabolism, Inflammation, and Cardiac Dimension Parameters"],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.06510909","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5807959.5789057","asserted-by":"object"}]},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}